Emmaus Life Sciences, Inc. Common Stock
EMMA
EMMA was delisted on the 10th of September, 2019.
9 hedge funds and large institutions have $147K invested in Emmaus Life Sciences, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 4 closing their positions.
25% less funds holding
Funds holding: 12 → 9 (-3)
26% less capital invested
Capital invested by funds: $198K → $147K (-$51K)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Top Buyers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$23.1K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.49K |
| 3 |
Morgan Stanley
New York
|
+$416 |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$377 |
Top Sellers
| 1 |
Jane Street
New York
|
-$35K |
| 2 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$8K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$8K |
| 4 |
HFM
Hartford Financial Management
Hartford,
Connecticut
|
-$5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $72K | +$23.1K | +2,332 | +44% |
|
|
CC
2
Cannell & Co
New York
| $32K | – | – | – |
|
|
FFA
3
First Foundation Advisors
Irvine,
California
| $25K | – | – | – |
|
|
4
Vanguard Group
Malvern,
Pennsylvania
| $18K | +$1.49K | +150 | +8% |
|
|
5
Jane Street
New York
| – | -$35K | -3,203 | Closed |
|
|
6
UBS Group
Zurich,
Switzerland
| – | -$8K | -726 | Closed |
|
|
PAM
7
Panagora Asset Management
Boston,
Massachusetts
| – | -$8K | -709 | Closed |
|
|
HFM
8
Hartford Financial Management
Hartford,
Connecticut
| – | -$5K | -483 | Closed |
|
|
9
Bank of America
Charlotte,
North Carolina
| – | +$377 | +38 | +380% |
|
|
10
Morgan Stanley
New York
| – | +$416 | +42 | New |
|
EMMA Hedge Fund Activity: Q3 2018 in Review
9 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Emmaus Life Sciences, Inc. Common Stock (EMMA) for Q3 2018, worth a combined $147K — down 26% from $198K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of EMMA and 1 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 3 added.
The largest buyer was Susquehanna International Group, adding an estimated $23.1K. The largest seller was Jane Street, exiting entirely with an estimated $35K sold.
- 9 institutional investors held Emmaus Life Sciences, Inc. Common Stock (EMMA) as of Q3 2018, down from 12 in Q2 2018.
- Funds reported $147K of Emmaus Life Sciences, Inc. Common Stock stock for Q3 2018, down 26% quarter-over-quarter.
- 1 fund opened new Emmaus Life Sciences, Inc. Common Stock positions in Q3 2018 and 4 closed out, a net change of -3 holders.
- The largest Emmaus Life Sciences, Inc. Common Stock buyer in Q3 2018 was Susquehanna International Group, an estimated $23.1K added.
- The largest Emmaus Life Sciences, Inc. Common Stock seller in Q3 2018 was Jane Street, an estimated $35K sold.
Based on aggregated 13F filings for Q3 2018.